Join to View Full Profile
300 Longwood Ave3RD floor HunnewellBoston, MA 02115
Phone+1 617-355-7796
Dr. Softness is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Fellow | Pediatric Urology | Boston Children's Hospital | Harvard-Wide Pediatric Health Services Research Fellow
Education & Training
Boston Children’s Hospital//Harvard Medical SchoolFellowship, Pediatric Urology, 2023 - 2026
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Urology, 2019 - 2023
Jefferson Health Medical Education/Jefferson Einstein Philadelphia HospitalResidency, Radiology-Diagnostic, 2018 - 2019
Albert Einstein Medical CenterInternship, Transitional Year, 2017 - 2018
Georgetown University School of MedicineClass of 2017
Certifications & Licensure
MA State Medical License 2019 - 2025
WI State Medical License 2024 - 2025
PA State Medical License 2017 - 2019
Publications & Presentations
PubMed
- Self-adjusted Nitrous Oxide During Urodynamic Studies Reduces Patient Pain Without Compromising Study Quality: A Randomized Controlled Trial.Abigail J Escobar, Ranveer Vasdev, Mary Gallo, Kenneth Softness, Hsin-Hsiao Scott Wang
European Urology Open Science. 2024-10-01 - 9 citationsOnabotulinumtoxin A (Botox): A reasonable alternative for refractory neurogenic bladder dysfunction in children and young adultsKenneth Softness, Hatim Thaker, Didi Theva, Archana Rajender, Bartley G. Cilento
Neurourology and Urodynamics. 2021-09-06 - 1 citationsAccess to male fertility preservation information and referrals at National Cancer Institute Cancer Centers.Kenneth Softness, Taylor P. Kohn, Aaron Perecman, Robert Carrasquillo
Andrologia. 2021-03-09
Press Mentions
Comparative Effectiveness of Radical Cystectomy and Trimodality Therapy for Muscle-Invasive Bladder Cancer – Boris GershmanFebruary 11th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
